U.S. Diversified Financial Stock News

Legacy Education (LGCY) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue figures around US$19.4 million in Q1 2026 and US$19.2 million in Q2 2026, alongside basic EPS of US$0.18 and US$0.16 respectively. This sets the backdrop for its latest update at a share price of US$11.92. Over the past year, the company has seen total revenue move from US$52.7 million to US$75.1 million and trailing 12 month EPS lift from US$0.62 to US$0.66, giving investors a clear sense of...

In early May 2026, Texas Roadhouse, Inc. reported first-quarter revenue of US$1.63 billion and net income of US$123.43 million, with diluted earnings per share rising to US$1.87 and the board affirming a US$0.75 quarterly dividend. Management also issued 2026 guidance calling for positive comparable restaurant sales growth supported by menu pricing actions, highlighting how the chain is using selective price increases to help manage inflation-driven cost pressures while maintaining...

In early May 2026, The Hackett Group reported first-quarter 2026 results showing lower sales and revenue than a year earlier but higher net income and earnings per share, reaffirmed its US$0.12 quarterly dividend, detailed recent share repurchases under its long-running buyback, and filed a US$3.47 million ESOP-related common stock shelf registration. Ahead of its AI-focused transition and new global collaboration with IBM, Hackett also issued second-quarter 2026 revenue guidance and...

Capital Southwest (CSWC) is back in focus after reporting full year 2026 results, with revenue of US$232.11 million, net income of US$113 million, and basic earnings per share from continuing operations of US$1.98. See our latest analysis for Capital Southwest. At a share price of US$23.57, the stock has eased slightly in the short term, with modest share price gains year to date but much stronger multi year total shareholder returns, which suggests that momentum has been building over...

Synopsys (SNPS) stock has drawn investor attention after recent trading, with the share price closing at US$502.42. Recent moves now sit against a one-month gain of 14.6% and a three-month return of 14.9%. See our latest analysis for Synopsys. The recent pullback over the past week sits against a stronger 30-day share price return of 14.6% and a 90-day gain of 15.0%. The 1-year total shareholder return is slightly negative, and the 5-year total shareholder return is a little more than double...

Recent stock performance sets the backdrop Levi Strauss (LEVI) stock has pulled back over the past week and month, with returns down 7.5% and 5.8% respectively, even as the past year shows a total return of 21.9%. See our latest analysis for Levi Strauss. The recent pullback in Levi Strauss, including a 7 day share price return down 7.5% and a weaker 90 day share price return, contrasts with a 1 year total shareholder return of 21.9%. This suggests momentum has cooled after a strong run. If...

WeRide (NasdaqGM:WRD) reports record Q1 2026 revenue, supported by expanded robotaxi and ADAS operations. The company launches fully driverless robotaxi services in Dubai, Abu Dhabi, and Singapore, growing its presence outside China. WeRide introduces its Genesis simulation platform, designed to speed up training of autonomous driving AI models. WRD 3.0 receives top honors in China's urban driving competitions, highlighting progress in complex city environments. For investors tracking...

Pfizer stock snapshot and recent performance Pfizer (PFE) is back in focus for investors, with the stock closing at US$25.33 and showing mixed performance, including a gain over the past year alongside declines over the past month and past 3 months. See our latest analysis for Pfizer. Recent trading has been weak, with the share price return down 6.84% over the past 30 days and 8.16% over 90 days. The 1 year total shareholder return is 18.70%, which suggests earlier momentum has cooled as...

Wondering whether Affirm Holdings at around US$65.82 is still worth your attention, or if the latest excitement has already been priced in? The stock has recently moved 2.8% over the past week and 10.4% over the past month, while the year to date return is down 11.1% and the 1 year return sits at 25.2%. Those swings sit against a backdrop of ongoing interest in buy now, pay later platforms and broader conversations about the role of consumer financing in online and in store spending...

Mirum Pharmaceuticals: recent performance snapshot Mirum Pharmaceuticals (MIRM) has attracted attention after a strong year to date, with the stock up about 31% and a total return of roughly 127% over the past year. See our latest analysis for Mirum Pharmaceuticals. After this strong run, the share price has recently cooled, with the latest close at $102.19, a 1 day share price return of down 8.3% and a 7 day share price return of down 4.6%. The 1 year total shareholder return remains very...

In early May 2026, Dollar General launched simmer & stir, a private-label kitchen brand offering nearly 30 modern, functional tools priced at US$12 or less, rolling out to about 16,000 stores nationwide. This new line, alongside recent seasonal collections and retail media expansion, highlights Dollar General’s push to pair low prices with more stylish, higher-margin home and lifestyle offerings. Against this backdrop, we’ll explore how simmer & stir’s value-focused, private-label expansion...

Integra LifeSciences Holdings recently reported first-quarter 2026 results with sales of US$391.92 million, a smaller net loss of US$4.62 million, reaffirmed full-year revenue guidance, and raised its full-year adjusted EPS outlook following the appointment of long-time board chair Stuart Essig as CEO and president. These updates, alongside a modest ESOP-related shelf registration and fresh equity awards to directors, suggest management is tightening operational focus while more closely...

CG Oncology has reported first-quarter 2026 results, with revenue rising to US$1.08 million while net loss widened to US$60.20 million, and is preparing to share initial Phase 2 CORE-008 data on its intravesical combination therapy for high-risk non-muscle invasive bladder cancer at the AUA 2026 Annual Meeting. The upcoming CORE-008 presentations, alongside fellowship-backed research on tumor microenvironment and heterogeneity in BCG-unresponsive disease, underscore CG Oncology’s focus on...

Linde (LIN) stock is back in focus after the company issued €1.6b in euro notes, shortly after reporting Q1 2026 sales growth of 8% and adjusted EPS of US$4.33, with further EPS gains projected for Q2. See our latest analysis for Linde. Linde’s recent euro note issuance and Q1 update come after a steady run in the stock, with the share price at US$506.11, a 17.94% year to date share price return and a 12.05% one year total shareholder return, signalling momentum that has been positive rather...

Investors may be wondering whether M&T Bank stock still offers value at current levels, or if most of the upside has already been priced in. The stock last closed at US$204.90, with returns that slipped 3.4% over the past week and 5.6% over the past month, while still showing gains of 0.4% year to date, 12.4% over 1 year, 86.2% over 3 years, and 47.8% over 5 years. Recent coverage around M&T Bank has focused on its positioning within the US banking sector and how investors are reassessing...

Qualys (NasdaqGS:QLYS) received FedRAMP High Authorization for its TotalCloud platform, clearing it for broader use by U.S. federal agencies and other regulated entities. The company also announced a partnership with Converge to automate cyber risk reporting and link customers more directly to potential cyber insurance premium reductions. These developments highlight Qualys' focus on automated, compliance ready cloud security and tighter integration between security tools and insurance...

On May 15, 2026, Trillium Asset Management filed an exempt solicitation urging Target shareholders to vote against Executive Chair Brian Cornell and Lead Independent Director Christine Leahy at the June 10 annual meeting, citing concerns over leadership and prior decisions. At the same time, Target is broadening its wellness, functional food, and men’s personal care offerings through new exclusive and nationwide brand launches, underscoring a push to refresh in-store assortments while...

In early May 2026, ANI Pharmaceuticals reported first-quarter sales of US$237.46 million and net income of US$29.49 million, raised its 2026 revenue guidance to US$1.08–US$1.14 billion, and authorized a US$100 million share repurchase program funded from cash resources. The company also highlighted accelerating momentum in its Rare Disease segment, with Cortrophin Gel and other specialty products expected to account for around 60% of 2026 revenues, even as several senior executives and...

Boeing (BA) is back in the spotlight after securing a long awaited 200 aircraft order from China during the Beijing summit, a deal that reopened the market yet still triggered a sharp share price drop. See our latest analysis for Boeing. The China order arrives after a choppy stretch, with the stock down 3.8% on the day and recording a 7.1% decline over the past week, even as the 1 year total shareholder return of 7.1% and 3 year total shareholder return of 7.3% point to relatively modest...

Tutor Perini Corporation recently reported first-quarter 2026 results, with sales rising to US$1,389.46 million from US$1,246.63 million a year earlier, while net income eased to US$25.7 million and diluted earnings per share from continuing operations slipped to US$0.48 from US$0.53. Alongside these mixed earnings trends, the company affirmed a quarterly dividend of US$0.06 per share payable on June 4, 2026, signaling an ongoing commitment to returning cash to shareholders despite lower...

Mitek Systems’ Verified Identity Platform is now listed on Fair Isaac (FICO) Marketplace, giving FICO Platform clients access to additional identity verification tools that can be plugged directly into fraud detection and customer workflows. See our latest analysis for Fair Isaac. Recent moves in FICO’s stock reflect that tension between product momentum and competitive risk, with a 1-day share price return of 2.01% and a year to date share price decline of 33.15%, while the 5 year total...

Investors may be wondering whether Banner at around US$62.58 is offering value right now, or if the easy gains are already behind it. The stock is roughly flat year to date with a 0.2% gain, after declining 4.7% over the last week and 1.2% over the past month, and is down 0.3% over the last year while still showing a 52.8% gain over three years and 24.2% over five years. Recent headlines around US regional banks and funding conditions have kept investor attention on balance sheet strength...

New York Times (NYT) stock has been drawing attention after a recent stretch of share price pressure, with the stock down 6% over the past week and 8% over the past month. See our latest analysis for New York Times. Despite the recent setback, the 1-year total shareholder return of 34.70% and 3-year total shareholder return of 113.76% suggest longer term momentum has been strong, even as short term share price performance has cooled. If this recent pullback has you thinking about where else...

CleanSpark (CLSK) stock is back in focus after the bitcoin miner reported a sharply wider Q2 net loss tied largely to noncash bitcoin revaluation, while emphasizing capacity growth for AI and high performance computing. See our latest analysis for CleanSpark. The stock has pulled back since the earnings release, with a 1-day share price return of down 6.22% and 7-day share price return of down 7.68%. At the same time, the 90-day share price return of 33.10% and 1-year total shareholder return...